Preconditioning: An endogenous defense against the insult of myocardial ischemia

Anesthesia and Analgesia

Volumn 83, Issue 3, 1996, Pages 639-645

  Martin, Hugh B ^a   Walter, Chris L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ADRENALIN; BRADYKININ; FREE RADICAL; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 70; NITRIC OXIDE; NORADRENALIN; POTASSIUM CHANNEL; PROTEIN KINASE C;

ARTICLE; COLLATERAL CIRCULATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

EID: 0029818878     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199609000-00037     Document Type: Article

References (53)

1. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. Przyklenk K, Kloner RA, Yellon DM. Ischemic preconditioning: the concept of endogenous cardioprotection. Boston: Kluwer Academic Publishers, 1994.
3. Reimer KA, Hill ML, Jennings RB. Prolonged depletion of ATP and the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol 1981;13:229-39.
4. Barber MJ. Effect of time interval between repeated brief coronary artery occlusions on arrythmias, electrical activity and myocardial blood flow. J Am Coll Cardiol 1983;3:699-705.
5. Reimer KA, Murray CE, Yamasawa I, et al. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986;251:H1306-15.
6. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
7. Li YW, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992;123:346-53.
8. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42.
9. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991;84:341-9.
10. Miura T, Ogawa T, Iwamoto T. Infarct size limiting effect of preconditioning: its duration and "dose-response" relationship. Circulation 1990;83:271.
11. Vegh A, Szekeres L, Parratt JR. Preconditioning of the ischaemic myocardium: involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992;107:625-48.
12. Vegh A, Szekeres L, Parratt JR. Does nitric oxide play a role in ischemic preconditioning? [abstract]. J Mol Cell Cardiol 1991;23:S72.
13. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
14. + channel opener RP 52891 reduces experimental infarct size in dogs in the absence of systemic hemodynamic changes. J Pharmacol Exp Ther 1991;259:961-7.
15. Auchampach JA, Maruyama M, Cavero I, Gross GJ. Pharmacological evidence for a role of ATP-regulated potassium channels in myocardial stunning. Circulation 1992;86:311-9.
16. D'Alonso AJ, Darbenzio RB, Parham CS, Grover GJ. Effects of intracoronary cromakalim on postischemic contractile function and action potential duration. Cardiovasc Res 1992;26:1046-53.
17. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
18. ATP) opener bimakalim mimics preconditioning in swine [abstract]. Circulation 1992;86(Suppl 4):1555.
19. Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44-9.
20. Toombs CF, Norman NR, Groppi VE, et al. Limitation of myocardial injury with the potassium channel opener cromakalim and the non-vasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivo. J Pharmacol Exp Ther 1992;263:1261-8.
21. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther 1993;265:559-64.
22. Grover GJ, McCullough JR, Henry DE, et al. The anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-110.
23. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-12.
24. + channel blocker. Circulation 1994;90:700-5.
25. + channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP. Proc Natl Acad Sci USA 1989;86:2971-5.
26. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993;72:13G-21G.
27. Weisfeldt ML. Reperfusion and reperfusion injury. Clin Res 1987;35:13-20.
28. Deleted in proof.
29. Tajima M, Katayose D, Bessho M, Isoyama S. Acute ischemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischemia. Cardiovasc Res 1994;28:312-9.
30. Walsh RS, Borges M, Thornton J, Cohen MV. Hypoxia preceding ischemia reduces infarction despite the lack of an intervening period of reoxygenation [abstract]. Circulation 1992;86:342.
31. Coker SJ, McGrath MT. Can captopril modify experimentally induced cardiac arrythmias? [abstract]. J Mol Cell Cardiol 1985;17:41.
32. Wall TM, Sheehy R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-9.
33. Deleted in proof.
34. Yellon DM, Pasini E, Cargnoni A, et al. The protective role of heat stress in the ischemic and reperfused rabbit myocardium. J Mol Cell Cardiol 1992;24:895-907.
35. Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischemia. Cardiovasc Res 1993;27:578-84.
36. Kucukoglu S, Iliodromitis E, Van Winkle D, et al. Protection by ischaemic preconditioning appears independent of stress protein synthesis [abstract]. J Mol Cell Cardiol 1991;23:S73.
37. Currie RW. Effects of ischemia and perfusion temperature on the synthesis of stress-induced (heat shock) proteins in isolated and perfused rat hearts. J Mol Cell Cardiol 1987;19:795-808.
38. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991;260:H796-804.
39. Matsuda M, Catena TG, Vander Heide RS, et al. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning. Cardiovasc Res 1993;27:585-92.
40. Miura T, Goto M, Urabe K, et al. Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation 1991;84:2504-12.
41. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
42. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-90.
43. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661-8.
44. Toombs CF, Wiltse AL, Shebuski RJ. Ischemic preconditioning fails to limit infarct size in reserpined myocardium. Implication of norepinephrine release in the preconditioning effect. Circulation 1993;88:2351-8.
45. Ely SW, Mentzer RM, Lasley RD, et al. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 1985;90:549-56.
46. Forman MB, Velasco CE, Jackson EK. Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc Res 1993;27:9-17.
47. 1-adenosine receptor agonist, protects against ischaemic arrythmias in pigs [abstract]. J Mol Cell Cardiol 1991;23:S125.
48. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993;27:3-8.
49. ATP channels. Circulation 1994;89:1229-36.
50. Li Y, Kloner RA. The cardioprotective effects of ischemic "preconditioning' are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-8.
51. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
52. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Col Cardiol 1992;20:578-86.
53. Yoshikawa T, Inoue S, Abe S, et al. Acute myocardial infarction without warning: clinical characteristics and significance of preinfarction angina. Cardiology 1993;82:42-7.